These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11555548)

  • 1. Mometason furoate levels.
    Lipworth BJ
    Chest; 2001 Sep; 120(3):1034-5. PubMed ID: 11555548
    [No Abstract]   [Full Text] [Related]  

  • 2. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
    Affrime MB; Banfield C; Nolop K
    Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology.
    Derendorf H; Daley-Yates PT; Pierre LN; Efthimiou J
    Eur Respir J; 2001 Jan; 17(1):157-8. PubMed ID: 11307748
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T; Cutler DL; Staudinger H; Herron JM
    Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
    Skoner DP; Meltzer EO; Milgrom H; Stryszak P; Teper A; Staudinger H
    J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M; Jarvis B
    Drugs; 2001; 61(9):1325-50. PubMed ID: 11511026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-a-day topical corticosteroids.
    Drug Ther Bull; 1995 Mar; 33(3):21-2. PubMed ID: 7587987
    [No Abstract]   [Full Text] [Related]  

  • 11. Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis.
    Swinehart JM; Barkoff JR; Dvorkin D; Fisher G; Peets E
    Int J Dermatol; 1989 Dec; 28(10):680-1. PubMed ID: 2687182
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
    Gregurek-Novak T
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):81-2. PubMed ID: 11451336
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic index makes easier the choice of admissible substances. No fear concerning cortisone].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587199
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma.
    Skoner DP; Gentile DA; Angelini B
    Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal suppression with mometasone furoate/formoterol.
    Lipworth BJ
    Chest; 2014 May; 145(5):1175-1176. PubMed ID: 24798853
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study.
    Ow R; Groppo E; Clutter D; Gawlicka AK
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):816-22. PubMed ID: 25256638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice.
    Ogawa M; Sakonjo H; Kamei C
    Immunopharmacol Immunotoxicol; 2009; 31(4):601-6. PubMed ID: 19874229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mometasone furoate].
    Veien NK
    Ugeskr Laeger; 1991 Sep; 153(40):2848-50. PubMed ID: 1926632
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled glucocorticoids for asthma.
    Barnes PJ
    N Engl J Med; 1995 Mar; 332(13):868-75. PubMed ID: 7870143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.